title: [Secondary prevention after myocardial infarction].
abstract: A significant reduction in cardiovascular mortality has been achieved during the last decade. New techniques and materials for early coronary intervention have contributed significantly to reduce early mortality after myocardial infarction. Secondary prevention determines further progress; it combines evidence-based medical treatment as well as lifestyle modifications. ACE inhibitors, angiotensin receptor blockers, and beta-blocker positively affect elevated blood pressure, left ventricular remodeling, and electrical stability. Statins decrease LDL and increase HDL cholesterol. Acetylsalicylic acid and clopidogrel are indicated for antiplatelet therapy. Lifestyle modifications unite a diet rich in polyunsaturated fatty acids, moderate physical activity, weight reduction, and smoking cessation.
authors.affiliation: Medizinische Klinik 2, Städtisches Klinikum Braunschweig gGmbH, Salzdahlumer Strasse 90, Braunschweig, Germany.
authors.forename: J E
authors.initials: JE
authors.lastname: Pflumm
authors.forename: T
authors.initials: T
authors.lastname: Pomykaj
authors.forename: M P
authors.initials: MP
authors.lastname: Heintzen
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D055502:Secondary Prevention
chemical_list: D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors